2025: Digital Asset Insights You Need to Know

Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.

Wetteny N. Joseph net worth and biography

Wetteny Joseph Biography and Net Worth

Exec. VP & CFO of Zoetis

Wetteny Joseph is the Chief Financial Officer of Zoetis which discovers, develops, manufactures, and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company markets its products in North America, Europe, Africa, Asia, Australia, and Latin America. Previously Mr. Joseph was the Senior Vice President and Chief Financial Officer of Catalent Inc. (“Catalent”). Mr. Joseph brings significant management and life sciences industry experience to the Board of Directors, as well as knowledge in the areas of public company finance, accounting, business strategy, business operations, and international operations. Previously, Mr. Joseph held various leadership positions within Catalent including President, Clinical Supply Services and Vice President, Finance. Mr. Joseph holds a Bachelor of Science degree and a Master of Accounting degree both from Florida Atlantic University.

How old is Wetteny N. Joseph?: Mr. Joseph is currently 52 years old. There are 7 older executives and no younger executives at Zoetis. The oldest executive at Zoetis is Ms. Roxanne Lagano, EVP, Chief HR Officer & Global Operations, Interim General Counsel and Corporate Secretary, who is 59 years old. Learn More on Wetteny N. Joseph's age.
How do I contact Wetteny N. Joseph?: The corporate mailing address for Mr. Joseph and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Wetteny N. Joseph's contact information.
Has Wetteny N. Joseph been buying or selling shares of Zoetis?: Wetteny N. Joseph has not been actively trading shares of Zoetis within the last three months. Learn More on Wetteny N. Joseph's trading history.
Who are Zoetis' active insiders?: Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.
Are insiders buying or selling shares of Zoetis?: In the last twelve months, insiders at the sold shares 5 times. They sold a total of 5,632 shares worth more than $1,047,983.01. The most recent insider tranaction occured on April, 18th when EVP Roxanne Lagano sold 923 shares worth more than $139,529.91. Insiders at Zoetis own 0.2% of the company. Learn More about insider trades at Zoetis.
Information on this page was last updated on 4/18/2024.

Wetteny N. Joseph Insider Trading History at Zoetis

Wetteny N. Joseph Buying and Selling Activity at Zoetis

Zoetis Company Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $176.98

$176.00

$178.07

50 Day Range

MA: $185.62

$170.37

$196.48

2 Week Range

Now: $176.98

$144.80

$201.92

Volume

1,854,572 shs

Average Volume

2,832,691 shs

Market Capitalization

$79.85 billion

P/E Ratio

33.27

Dividend Yield

0.98%

Beta

0.9

2025: Digital Asset Insights You Need to Know

From Darwin | Ad

Get your guide today!